Nektar Therapeutics (NKTR)
$1.01 $0.02 (2.50%) 10:59 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$186.30M -
Day's Range
$0.99 - $1.03 -
Volume
2,356,393 -
52 Week Low / High
$0.46 - $1.93 -
PE Ratio
- -
PEG Ratio
3.22 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 2
- Buy
- 3
- Hold
- 1
- Sell
- 0
- Strong Sell
- $2.88
- Target Price
Company News
-
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 — Sep 25th, 2024
- New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis - SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR)...
-
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 — Sep 25th, 2024
- New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis - SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR)...
Portfolio
Comprised of 1 portfolios